Literature DB >> 17659440

The impact of diabetes on survival following breast cancer.

Lorraine L Lipscombe1, Pamela J Goodwin, Bernard Zinman, John R McLaughlin, Janet E Hux.   

Abstract

PURPOSE: It has been suggested that type 2 diabetes may affect breast cancer prognosis, possibly due to increased diabetes-related comorbidity, or direct effects of insulin resistance and/or hyperinsulinemia. The purpose of this study was to examine the impact of diabetes on survival following breast cancer.
METHODS: Using population-based health databases from Ontario, Canada, this retrospective cohort study compared deaths between women with breast cancer aged 55-79 years with diabetes and without diabetes. Women were followed for all cause mortality from breast cancer diagnosis until March 31st 2006.
RESULTS: Of the 6,107 women with breast cancer, 1,011 had diabetes and 5,096 did not have diabetes. Women with diabetes were slightly older, were more likely to reside in a lower income neighborhood, and had greater comorbidity compared to women without diabetes. After a mean follow-up of 5.0 years and adjustment for age, prior mammograms and other covariates, mortality following breast cancer was significantly higher among women with versus without diabetes (hazard ratio, HR 1.39, 95% confidence interval, CI 1.22-1.59, P < 0.0001). The effect of diabetes on mortality was comparable to that seen in women with diabetes without breast cancer over a 7-year follow-up.
CONCLUSION: This study found that diabetes was associated with a close to 40% increase in mortality within the first 5 years following breast cancer, which was similar to that seen in women with diabetes without breast cancer. These findings suggest that early survival following breast cancer is reduced in women with diabetes, possibly due to diabetes-related causes.

Entities:  

Mesh:

Year:  2007        PMID: 17659440     DOI: 10.1007/s10549-007-9654-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  77 in total

1.  Diabetes, diabetes treatment and breast cancer prognosis.

Authors:  Juhua Luo; Beth Virnig; Michael Hendryx; Sijin Wen; Rowan Chelebowski; Chu Chen; Tomas Rohan; Lesley Tinker; Jean Wactawski-Wende; Lawrence Lessin; Karen Margolis
Journal:  Breast Cancer Res Treat       Date:  2014-09-27       Impact factor: 4.872

2.  Incidence of diabetes among postmenopausal breast cancer survivors.

Authors:  L L Lipscombe; W W Chan; L Yun; P C Austin; G M Anderson; P A Rochon
Journal:  Diabetologia       Date:  2012-12-13       Impact factor: 10.122

Review 3.  Metformin and cancer.

Authors:  Natalia G Vallianou; Angelos Evangelopoulos; Christos Kazazis
Journal:  Rev Diabet Stud       Date:  2014-02-10

4.  Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.

Authors:  Wen-Yi Shau; Yu-Yun Shao; Yi-Chun Yeh; Zhong-Zhe Lin; Raymond Kuo; Chih-Hung Hsu; Chiun Hsu; Ann-Lii Cheng; Mei-Shu Lai
Journal:  Oncologist       Date:  2012-05-23

Review 5.  BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer.

Authors:  Dequina A Nicholas; Guillaume Andrieu; Katherine J Strissel; Barbara S Nikolajczyk; Gerald V Denis
Journal:  Cell Mol Life Sci       Date:  2016-08-04       Impact factor: 9.261

6.  Improving health engagement and lifestyle management for breast cancer survivors with diabetes.

Authors:  Rebecca A Shelby; Caroline S Dorfman; Sarah S Arthur; Hayden B Bosworth; Leonor Corsino; Linda Sutton; Lynda Owen; Alaattin Erkanli; Francis Keefe; Cheyenne Corbett; Gretchen Kimmick
Journal:  Contemp Clin Trials       Date:  2020-04-11       Impact factor: 2.226

7.  Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population.

Authors:  Aruna Kamineni; Melissa L Anderson; Emily White; Stephen H Taplin; Peggy Porter; Rachel Ballard-Barbash; Kathleen Malone; Diana S M Buist
Journal:  Cancer Causes Control       Date:  2012-12-07       Impact factor: 2.506

8.  Diabetes and cancer: a consensus report.

Authors:  Edward Giovannucci; David M Harlan; Michael C Archer; Richard M Bergenstal; Susan M Gapstur; Laurel A Habel; Michael Pollak; Judith G Regensteiner; Douglas Yee
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

9.  Long-term metformin use is associated with decreased risk of breast cancer.

Authors:  Michael Bodmer; Christian Meier; Stephan Krähenbühl; Susan S Jick; Christoph R Meier
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

10.  Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression.

Authors:  Yvonne Fierz; Ruslan Novosyadlyy; Archana Vijayakumar; Shoshana Yakar; Derek LeRoith
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.